Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · IEX Real-Time Price · USD
0.289
+0.003 (1.12%)
At close: Apr 25, 2024, 4:00 PM
0.280
-0.009 (-3.18%)
After-hours: Apr 25, 2024, 7:55 PM EDT
Daré Bioscience Stock Forecast
DARE's stock price has decreased by -70.79% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Daré Bioscience stock has a target of 6.00, which predicts an increase of 1,974.69% from the current stock price of 0.29.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for DARE stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Brookline Capital | Brookline Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +1,974.69% | Apr 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $6 | Strong Buy | Maintains | $7 → $6 | +1,974.69% | Nov 10, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +2,320.47% | Aug 11, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +2,320.47% | Jul 13, 2023 |
Financial Forecast
Revenue This Year
7.10M
from 2.81M
Increased by 152.93%
Revenue Next Year
34.03M
from 7.10M
Increased by 379.22%
EPS This Year
-0.26
from -0.35
EPS Next Year
-0.06
from -0.26
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 17.9M | 62.5M | 119.4M | 225.2M | 372.6M |
| Avg | 7.1M | 34.0M | 64.5M | 184.4M | 300.7M |
| Low | n/a | 7.1M | 12.6M | 141.8M | 211.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 535.7% | 779.9% | 250.8% | 249.1% | 102.1% |
| Avg | 152.9% | 379.2% | 89.6% | 185.8% | 63.1% |
| Low | - | -0.4% | -63.1% | 119.7% | 14.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.21 | 0.11 | 0.36 | 1.00 | 1.63 |
| Avg | -0.26 | -0.06 | 0.09 | 0.88 | 1.43 |
| Low | -0.31 | -0.22 | -0.17 | 0.75 | 1.23 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 1,050.5% | 85.5% |
| Avg | - | - | - | 911.8% | 62.8% |
| Low | - | - | - | 770.4% | 39.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.